Molecular Characterization of c-Abl/c-Src Kinase Inhibitors Targeted against Murine Tumour Progenitor Cells that Express Stem Cell Markers

• Thomas Kruewel ,

  Contributed equally to this work with: Thomas Kruewel, Silvia Schenone, Marco Radi, Maurizio Botta

  Affiliations Center for Pharmacology and Toxicology, Hannover Medical School, Hannover, Germany, Department of Molecular Medicine and Medical Biotechnology, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany

  ⨯
• Silvia Schenone ,

  Contributed equally to this work with: Thomas Kruewel, Silvia Schenone, Marco Radi, Maurizio Botta

  Affiliation Department of Pharmaceutical Science, University of Genoa, Genoa, Italy

  ⨯
• Marco Radi ,

  Contributed equally to this work with: Thomas Kruewel, Silvia Schenone, Marco Radi, Maurizio Botta

  Affiliation Department of Chemistry and Pharmaceutical Technology, University of Siena, Siena, Italy

  ⨯
• Giovanni Maga,

  Affiliation Institute of Molecular Genetics IMG-CNR, Pavia, Italy

  ⨯
• Astrid Rohrbeck,

  Affiliations Center for Pharmacology and Toxicology, Hannover Medical School, Hannover, Germany, Department of Molecular Medicine and Medical Biotechnology, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany

  ⨯
• Maurizio Botta ,

  Contributed equally to this work with: Thomas Kruewel, Silvia Schenone, Marco Radi, Maurizio Botta

  Affiliation Department of Chemistry and Pharmaceutical Technology, University of Siena, Siena, Italy

  ⨯
• Juergen Borlak

  * E-mail: borlak@item.fraunhofer.de

  Affiliations Center for Pharmacology and Toxicology, Hannover Medical School, Hannover, Germany, Department of Molecular Medicine and Medical Biotechnology, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany

  ⨯